Results 141 to 150 of about 21,135 (199)

Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083. [PDF]

Open Forum Infect Dis
Moore HP, Fogel JM, Marzinke MA, Halvas EK, Parikh UM, Mellors JW, Penrose KJ, Seisa M, Petropoulos C, Price AL, Moser A, Wang Z, McCauley M, Valencia-Huamaní J, Rinehart AR, Rooney JF, Soto-Torres L, Grinsztejn B, Landovitz RJ, Eshleman SH.   +19 more
europepmc   +1 more source

Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study. [PDF]

Open Forum Infect Dis
Li A, Li Z, Li J, Gao Y, Dai L, Liu A, Zhang H, Wang X, Wu L, Yao Y, Liu L, Ye J, Sun L.   +12 more
europepmc   +1 more source

Doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/ TDF) treatment in people living with HIV: A single-center real-world experience from Belgrade, Serbia. [PDF]

Germs
Markovic M, Ranin J, Despotovic A, Rajkovic I, Ranin J, Tanasijevic M, Mitrovic N, Nikolic N, Milosevic I, Gmizic I.   +9 more
europepmc   +1 more source

Comparative effectiveness and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in patients with HBV-associated decompensated cirrhosis: insights from a retrospective analysis. [PDF]

BMC Infect Dis
Chen L, Zhang HF, Cai YJ, Zhang L, Cai C, Lu MQ, Zhu YY.   +6 more
europepmc   +1 more source

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment. [PDF]

Aliment Pharmacol Ther
Wong GL, Gane E, Pan CQ, Fung S, Ma MM, Izumi N, Shalimar, Lim SG, Chuang WL, Mehta R, Lim YS, Yee LJ, Flaherty JF, Abramov F, Wang H, Buti M.   +15 more
europepmc   +1 more source

Efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in HIV treatment: a real-world single-center study in China. [PDF]

Front Med (Lausanne)
Li A, Liu L, Zhang H, Wang X, Li Z, Liu A, Dai L, Zhang J, Gao Y, Ye J, Li J, Sun L.   +11 more
europepmc   +1 more source

Effect of weight gain on blood pressure in Ugandan persons with HIV on dolutegravir/lamivudine/ tenofovir disoproxil fumarate over 48 weeks. [PDF]

PLoS One
Amutuhaire W, Castelnuovo B, Brusselaers N, Nabwana M, Muhammad L, Maloney B, Nixon B, Schwarz JM, Mulindwa F.   +8 more
europepmc   +1 more source

Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial. [PDF]

Clin Mol Hepatol
Yim HJ, Seo YS, Kim JH, Kim W, Jung YK, Jang JY, Lee SH, Kim YS, Kim CW, Kim HS, Shim JJ, Cho EY, Kim IH, Lee BS, Lee JH, Kim BS, Jang JW, Lee HW, Kwon JH, Kim MY, Song DS, Park JG, Lee YS, Yoon EL, Lee HA, Kang SH, Yang JM.   +26 more
europepmc   +1 more source

Impact of stopping Tenofovir disoproxil fumarate at various times on elevated postpartum ALT levels and breastfeeding in pregnant women with chronic hepatitis B: a prospective observational cohort study. [PDF]

BMC Pregnancy Childbirth
Li S, Jiang Y, Shi J, Jiang X, Li Y, Ma Z, Jin J.   +6 more
europepmc   +1 more source

Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy. [PDF]

PLoS One
Lin Y, Lin X, Xia R, Chen J, Lin Z, Lu S.   +5 more
europepmc   +1 more source